جست‌وجوی استاد و پژوهشگر

• Power Electronics
• Pulse Width Modulation (PWM) Techniques
• Multilevel Converters
• +۵ مورد دیگر

Ahmed Ismail Mohamed Ali is an Assistant Professor at the Department of Electrical Engineering , Faculty of Engineering , South Valley University , Egypt, and a Post-Doctoral Research Fellow at Aalto University , Finland. He holds a B.Sc. and M.Sc. in Electrical Engineering from South Valley University (2013, 2017) and a Ph.D. in Electrical Engineering from Nagoya Institute of Technology , Japan (2022). Education: B.Sc. in Electrical Engineering, South Valley University (2013) M.Sc. in Electrical Engineering, South Valley University (2017) Ph.D. in Electrical Engineering, Nagoya Institute of Technology (2022) Research Interests include power electronics, specifically PWM techniques for bidirectional AC/DC converters , single-phase and three-phase multilevel converters , modular multilevel converters (MMCs) , isolated grid-tied differentially based DC-AC inverters , EV battery chargers , and renewable energy applications . His work focuses on improving efficiency, power quality, and complexity in renewable energy systems and electric vehicle charging infrastructure. Publications (15 most recent) span 2018–2025, with a strong emphasis on photovoltaic (PV) inverters , multilevel converter topologies , model predictive control (MPC) , and leakage current minimization . Recent work (2024–2025) explores advanced modulation strategies and grid-tied renewable energy integration. Laboratory Affiliation: He is part of the Computational Electromechanics research group at Aalto University, contributing to postdoctoral research in power electronics and renewable energy systems.

Hani El-Nezamyمشاهده پروفایل

استاد

• Gut Microbiota
• Probiotics
• Food Safety
• +۷ مورد دیگر

Hani El-Nezamy is a Professor at the Institute of Public Health and Clinical Nutrition , part of the School of Medicine at the University of Eastern Finland . His research focuses on gut health, microbial therapy for liver diseases, and food safety through microbiota modulation. Key Research Areas : Gut microbiota interactions, probiotic applications, mycotoxin mitigation, liver disease management, and nanoparticle toxicology Notable Collaborators : Emily Kwun Kwan Lo, Congjia Chen, Marsena Jasiel Ismaiah, Fangfei Zhang His 15 most recent publications (2023-2025) demonstrate expertise in probiotic interventions for metabolic and liver diseases, mycotoxin effects on gut epithelium, engineered microbial therapies, and interactions between dietary compounds and gut microbiota. Articles span disciplines including hepatology, microbiome research, toxicology, nutritional biochemistry, and pharmacology. Current research projects include investigating engineered bacteria for metabolic diseases, analyzing microplastic effects on gut health, and developing probiotic adjuvants for cancer therapy. His work frequently employs mouse models , metagenomic analysis , and microbial engineering techniques.

Pasi Peltoniemiمشاهده پروفایل

استاد

• Electrical and Electronic Engineering
• Control and Systems Engineering
• Power Electronics
• +۳ مورد دیگر

Pasi Peltoniemi is a Full Professor (tenured) in the Department of Electrical Engineering at Lappeenranta-Lahti University of Technology LUT. He is affiliated with the LUT School of Energy Systems, focusing on advanced research in Electrical and Electronic Engineering, Control Systems, and Power Electronics. His work emphasizes sustainable energy systems, particularly Low-Voltage Direct Current (LVDC) distribution networks and high-power converter technologies. His research spans power electronics, renewable energy integration, and grid-forming converter systems. Notable contributions include studies on multilevel inverters, SiC semiconductor applications, and energy management strategies for hybrid systems. He has pioneered LVDC distribution network designs, including fault protection, grounding schemes, and customer-end inverter optimization. Key research areas include: Advanced power electronics and converter topologies Grid stability and renewable energy integration Marine and industrial energy systems LVDC distribution infrastructure and standards His publications highlight trends in grid-forming voltage source converters, high-power charging systems, and microgrid control. Peltoniemi has contributed to international standards like LVDC rules and collaborated on projects such as the Congo Grand Inga hydroelectric evaluation. He leads research initiatives on energy storage systems, fault detection in power converters, and smart grid functionalities. His work integrates experimental validation (e.g., laboratory test setups) with theoretical models for system optimization. Labs/Teams: Active in LUT's LVDC research platform, focusing on utility network implementations and converter technology. Collaborates on projects like the On-Grid Hydrogen Production with Solar Energy in Nordic Conditions.

• Biochemistry
• Cell Biology
• Molecular Biology
• +۵ مورد دیگر

Alejandro Da Silva Nascimento is affiliated with the Faculty of Science and Engineering at Åbo Akademi University, specifically within the Department of Biochemistry and Cell Biology . His research focuses on the interplay between cell adhesion, gene expression, and cellular stress responses. He holds a doctoral degree from Åbo Akademi University (2023), where he completed his thesis titled Intertwining Cell Adhesion, Gene Expression, and Stress . His research interests include molecular mechanisms underlying proteotoxicity, oxidative stress, and heat shock responses. Key topics include the role of heat shock factors (HSFs), cadherins in cell-cell adhesion, and transcriptional regulation under stress conditions. His work bridges biochemical processes and cellular survival strategies under adverse conditions. His publications highlight collaborations in understanding how HSFs modulate gene expression during stress and the protective role of cell adhesion molecules against proteotoxicity. While no specific awards are listed, his work has garnered significant attention, as evidenced by citations and media coverage of his 2020 study in Cell Reports . His research has been supported by peer-reviewed journals, and he has contributed to open-access publications. Details about grants or advising roles are not explicitly mentioned in the provided texts.

Ronald Österbackaمشاهده پروفایل

استاد

• Flexible and Printed Large Area Electronics
• Paper Electronics
• Charge Transport and Recombination in Thin Film Photovoltaic Materials
• +۶ مورد دیگر

Ronald Österbacka is a Professor and Director of the Åbo Akademi University Graduate School within the Faculty of Science and Engineering , Åbo Akademi University . His research focuses on Flexible and Printed Large Area Electronics , Paper Electronics , and Charge Transport in Photovoltaic Materials . Österbacka's work addresses UN Sustainable Development Goals such as Affordable Clean Energy and Climate Action. He has pioneered inverted organic solar cells with efficiency exceeding 18% and bioelectronic platforms for early disease detection. Recent publications highlight advancements in perovskite solar cell stability , single-molecule detection , and trap state density modeling . His research demonstrates expertise in materials science , renewable energy , and bioelectronic interfaces . Scientific awards : Professor Theodor Homéns Prize (2023) Knight of the Order of the White Rose of Finland (2018) Chancellor's Award for Research Excellence (2016) Member of The Finnish Society for Science and Letters (2007) Member of the Swedish Academy for Engineering Sciences in Finland (2006) Österbacka leads international collaborations including the Printable Electronics Research Center at SINANO and participates in peer review , editorial work , and public science communication .

• Biomedicine
• Optogenetics
• Protein Engineering
• +۳ مورد دیگر

Vladislav Verkhusha serves as Research Director at the University of Helsinki's Department of Anatomy and Supervisor for the Doctoral Programme in Biomedicine. His research integrates biomedicine, protein engineering, and advanced imaging techniques to develop optogenetic tools and biosensors. Research Focus: Primary interests include optogenetics, near-infrared fluorescent proteins, and biomedical imaging technologies. His work enables high-sensitivity deep-tissue visualization and manipulation of cellular processes, with applications in neuroscience and synthetic biology. Publication Trends: Recent articles (2024-2025) focus on near-infrared imaging probes, genetically encoded biosensors, and optogenetic manipulation. Key themes include protein engineering for enhanced imaging depth and precision in biological systems. Grants & Projects: Verkhusha akatemihanke 24-28 (Academy of Finland: €600,000, 2024-2028) Jane ja Aatos Erkon säätiö/Verkhusha (€626,001, 2023-2025) Magnus Ehrnrooth 2023/Vlad Verkhusha (2023-2024)

• Cancer Immunotherapy
• Oncolytic Virotherapy
• Gene Therapy
• +۳ مورد دیگر

Tatiana Kudling is a Doctoral Researcher at the Doctoral Programme in Clinical Research at the University of Helsinki, focusing on advanced cancer immunotherapy approaches using oncolytic adenoviruses. Her work explores gene-modified viral vectors encoding cytokines like TNFα and IL-2 to enhance immune responses against solid tumors. Email: tatiana.kudling@helsinki.fi Research Interests : Cancer immunotherapy, oncolytic virology, cytokine gene therapy, tumor microenvironment modulation, and immune checkpoint inhibitors. Her studies aim to overcome resistance to immunotherapies through viral vector engineering and combination strategies. Publication Trends : Over 28 research outputs (2017–2025) centered on oncolytic adenovirus applications in melanoma, ovarian, pancreatic, and renal cancers. Key themes include PD-L1 inhibition , Lymphocyte activation , and biomarker discovery for treatment monitoring. Collaborations : Co-authored with leading researchers in virotherapy (e.g., A. Hemminki, A. Kanerva) and immuno-oncology (e.g., M. Donia, J.M. Santos). Involved in clinical trials like PROTA (platinum-resistant ovarian cancer) and TUNIMO (solid tumors).

• Molecular Biology
• RNA Biology
• Genetics
• +۴ مورد دیگر

Susana D. A. Garcia serves as a University researcher at the Institute of Biotechnology, University of Helsinki, and acts as Supervisor in the Doctoral Programme in Integrative Life Science. Her work centers on molecular mechanisms of genetic disorders using Caenorhabditis elegans models, with significant contributions to RNA biology and mitochondrial dysfunction research. Her research spans Biochemistry, Cell and Molecular Biology, with specialized focus on RNA toxicity, trinucleotide repeat disorders, and aging mechanisms. Key investigations include Muscleblind-like protein functions, microRNA regulation, and p38 MAPK signaling pathways in lifespan determination. She employs C. elegans to model human neurodegenerative conditions and identify therapeutic targets for muscle and mitochondrial diseases. Analysis of her 15 most recent publications (2004-2025) reveals consistent emphasis on RNA-related pathologies, particularly CTG/CUG repeat expansions causing muscular and neurological dysfunction. Her work demonstrates evolutionary conservation of regulatory mechanisms from nematodes to humans, with growing focus on coenzyme-based interventions for mitochondrial disorders since 2021. Scientific recognition includes: 1st Prize from Orion Pharma Competition 'Making more efficient medicines' (2017) As doctoral program supervisor, Dr. Garcia mentors graduate students in Integrative Life Science. Her research operates within the Biocenter 2 facility at Viikinkaari 5, contributing to the University of Helsinki's leadership in molecular genetics and biomedicine through continuous publication in high-impact journals like Genetics and PLoS Genetics .

Marko Lehtonenمشاهده پروفایل

پژوهشگر

• Metabolomics
• Pharmacokinetics
• Analytical Chemistry
• +۳ مورد دیگر

Marko Lehtonen is a Research Director at the School of Pharmacy , Faculty of Health Sciences, University of Eastern Finland. His work focuses on metabolomics , pharmacokinetics , and analytical chemistry with applications in neuropharmacology , cardiovascular research , and nutritional science . His research spans multiple domains: Metabolomics : Systematic analysis of metabolic profiles in diseases like alcohol-related liver disease , rheumatoid arthritis , and neurodegeneration Drug Delivery : Mechanistic studies on LAT1 transporter for brain-targeted therapies and prodrug development Dietary Biomarkers : Identification of whole-grain metabolites , obesity-related shifts , and microbiota interactions Recent publications reveal trends in cross-species metabolite profiling , pregnancy-related biomarkers , and neuroinflammatory pathways . His collaborations span translational medicine (e.g., Parkinson's disease studies) and environmental toxicology (e.g., PCB 180 exposure analysis).

• Pharmacology
• Neuroscience
• Pain Research
• +۳ مورد دیگر

Pekka Rauhala serves as an Adjunct Professor (Docent) at the University of Helsinki's Faculty of Medicine, Department of Pharmacology within Medicum. He holds a Docent contract, acts as Supervisor in the Doctoral Programme in Drug Research, and maintains active visiting researcher status. His institutional presence spans decades with continuous research output from 1984 to 2025. Rauhala's research centers on pain mechanisms and opioid pharmacology, with deep specialization in spinal cord neuropharmacology, opioid tolerance development, and glial cell interactions. His work integrates molecular neuroscience, metabolomics, and drug delivery systems to investigate polyneuropathy, intrathecal pharmacokinetics, and neuroinflammatory pathways in chronic pain models. Primary methodologies involve rat-based experimental systems examining gene expression, microglial activation, and lymphatic transport mechanisms. Analysis of his 79 research outputs (including 15+ recent publications) reveals consistent focus on opioid-glial interfaces, with escalating emphasis on transcriptomic and metabolomic approaches since 2020. His publication trajectory demonstrates methodological evolution from classical pharmacokinetics toward multi-omics integration while maintaining core investigation of morphine tolerance mechanisms. Rauhala actively supervises doctoral candidates within the Drug Research Programme and collaborates through two major projects: the ongoing "Glia and pain" initiative and the completed EC-FP7 GLORIA project (2013-2018) targeting glial-opioid receptor interfaces for chronic pain therapeutics. His work involves significant cross-institutional partnerships with researchers including Eija Kalso, Mikko Airavaara, and Tiina Lilius. Based at Medicum's B211B facility (PO Box 63), he maintains dual email contacts and direct phone lines, reflecting ongoing laboratory engagement. His research group operates within Helsinki's pain neuroscience consortium, contributing to translational pain medicine through mechanistic studies of drug delivery systems and neuroimmune interactions.

• Molecular Biology
• Immunology
• Cell Biology
• +۳ مورد دیگر

Anna Aalto is a Researcher at the Faculty of Natural Sciences and Engineering within the Department of Biochemistry and Cell Biology at Åbo Akademi University. She is affiliated with the InFLAMES Flagship (Innovation Ecosystem based on the Immune System), focusing on health solutions. Her research emphasizes innate immunity, molecular signaling pathways, and neurodevelopmental disorders. Key research interests include: Ubiquitin signaling mechanisms in immune responses Proteasome dysfunction and laminopathies Neurodevelopmental disorders like Rubinstein-Taybi syndrome Inflammation regulation in sterile conditions Genetic mutations impacting cellular proteostasis Recent publications (2022–2024) highlight studies on Drosophila innate immunity, NF-κB pathway modulation, and structural-functional interactions in neurodevelopmental disorders. Her work frequently employs model organisms and patient cell systems. Collaborations span international teams studying laminopathies, HSF2-CBP interactions, and immunology. No awards were explicitly mentioned in the text.

• Food Science
• Biotechnology
• Sustainable Materials
• +۳ مورد دیگر

Kirsi Mikkonen is a Professor at the Department of Food and Nutrition Research, University of Helsinki, affiliated with the Faculty of Agriculture and Forestry and the Helsinki Institute of Sustainability Science. Her research focuses on valorizing biomass streams, particularly wood-derived hemicelluloses and fungal biomass, exploring their applications in sustainable materials such as food packaging, emulsions, and hydrocolloids. She holds a PhD in Food Technology (2009) and an MSc (2004) from the University of Helsinki, alongside a Docent title in Food Materials Science (2013). Her research integrates biopolymer functionality at interfaces, emphasizing sustainability and biodegradability. Key projects include the ERC-funded 'PARTIFACE' (2020–2025) and 'Novo Nordisk Foundation' grant (2022–2027). She teaches food technology courses and supervises doctoral, master’s, and bachelor’s theses. Notable achievements include the ERC Consolidator Grant and media recognition for her work on wood-based materials in food and cosmetics. Grants and collaborations span organizations like the Academy of Finland, Business Finland, and Jane and Aatos Erkko Foundation. Her work addresses climate-smart food systems and biorefinery innovations.

Timo Myöhänenمشاهده پروفایل

استاد

• Neurodegenerative Diseases
• Pharmacology
• Drug Development
• +۵ مورد دیگر

Professor Timo Myöhänen is a prominent academic at the University of Helsinki's Department of Pharmacology within the Faculty of Medicine Medicum. His work focuses on drug development targeting neurodegenerative diseases, particularly Parkinson's and tauopathies, through the study of prolyl oligopeptidase (POP) inhibitors and autophagy mechanisms. He holds a PhD in Pharmacy and has authored over 60 peer-reviewed publications. Affiliations: University of Helsinki, Department of Pharmacology, Faculty of Medicine Medicum Education: PhD in Pharmacy (2008), Docent in Pharmacology (2012) Research interests include alpha-synuclein aggregation, tau pathology, and the role of prolyl oligopeptidase in neurodegeneration. Notable projects involve developing novel small-molecule ligands for disease-modifying therapies. He has supervised multiple doctoral theses and serves on editorial and review boards for journals like Science Translational Medicine and Autophagy . Key achievements include the 2008 Farmasian tutkijakoulun väitöskirjapalkinto award and extensive grants funded by organizations like the Sigrid Jusélius Foundation and AddF. His work bridges basic pharmacology with clinical applications, emphasizing translational research in neurodegenerative therapies.

Maria Heilalaمشاهده پروفایل

پژوهشگر

• Hydrogel Material Science
• Nanocellulose Engineering
• Cell Factory Engineering
• +۴ مورد دیگر

Maria Heilala is a Doctoral Student and Visitor Faculty member at the University of Helsinki's School of Science, Department of Applied Physics, with research focus in Molecular Materials. She holds a Master's degree (2019) and Bachelor's degree (2017) in Natural Sciences from the University of Helsinki. Her research spans multiple interdisciplinary fields at the intersection of materials science and biomedical applications. Heilala specializes in hydrogel material science, particularly nanocellulose and alginate-based biomaterials, with applications in cancer research and immune cell modulation. Her work explores how matrix stiffness affects cancer cell behavior and immune responses, contributing significantly to understanding tumor microenvironments and developing novel biomaterial scaffolds. Analysis of her publications reveals a strong focus on developing advanced biomaterials for biomedical applications, particularly in cancer research and regenerative medicine. Her work demonstrates expertise in characterizing mechanical properties of biomaterials and their biological effects, with recent publications appearing in high-impact journals including Nature Communications and ACS Applied Materials and Interfaces. Scientific Awards: Best extended oral presentation (April 25, 2024) Working grant (2024) Heilala is actively involved in the GeneCellNano project (2024-present), a competence cluster focused on gene, cell, and nano therapy for chronic diseases treatment. She has presented her research at multiple international conferences between 2023-2025, demonstrating active engagement with the scientific community. Her media coverage, particularly regarding nanocellulose as animal-free hydrogels for biomedical research, indicates growing recognition of her work's societal impact. Her research activities are centered around developing novel biomaterial scaffolds that mimic biological environments for studying cancer progression and immune responses. The Molecular Materials research group at the Department of Applied Physics provides the infrastructure for her experimental work on nanocellulose hydrogels, 3D cell cultures, and mechanical characterization of biomaterials.

• Aptamer Biochemistry
• Nucleic Acid Engineering
• Gastric Cancer Therapy
• +۳ مورد دیگر

Yuanqiang Li is an active researcher in the Faculty of Science and Engineering, focusing on innovative cancer therapeutics. His work bridges biochemistry, nanotechnology, and oncology through advanced nucleic acid engineering. Research interests center on aptamer-DNAzyme frameworks for targeted gastric cancer therapy, with expertise in metal-nucleic acid hybrid systems. His recent publications demonstrate breakthroughs in self-delivering therapeutic platforms that eliminate traditional carrier requirements, enabling precise tumor targeting and catalytic drug activation. Current research trends emphasize carrier-free MNAzyme delivery systems and metal-dependent nucleic acid frameworks , showing significant potential in overcoming limitations of conventional cancer treatments through room-temperature stable catalytic DNA structures. Collaborative work spans international teams, with publications in high-impact journals demonstrating substantial scientific influence (51 combined Scopus citations). Key contributions address UN Sustainable Development Goals through biomedical innovation for improved global health outcomes. Laboratory efforts focus on translating nucleic acid therapeutics from bench to bedside, with current projects optimizing oligonucleotide-based frameworks for clinical gastric cancer applications through interdisciplinary partnerships in molecular engineering.